Free Trial

Joseph Thomas Analyst Performance

Analyst at Oppenheimer

Joseph Thomas is a stock analyst at Oppenheimer across a range of sectors, covering 2 publicly traded companies. Over the past year, Joseph Thomas has issued 2 stock ratings, including buy and hold recommendations. While full access to Joseph Thomas' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Joseph Thomas' coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
2 Last 0 Years
Buy Recommendations
50.00% 1 Buy Ratings
Companies Covered
2 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy50.0%1 ratings
Hold50.0%1 ratings
Sell0.0%0 ratings

Out of 2 total stock ratings issued by Joseph Thomas at Oppenheimer, the majority (50.0%) have been Buy recommendations, followed by 50.0% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
2 companies

Joseph Thomas, an analyst at Oppenheimer, currently covers 2 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Miscellaneous
1 company
50.0%
Consumer Staples
1 company
50.0%

Joseph Thomas of Oppenheimer specializes in stock coverage within the sector, with additional focus on Consumer Staples companies.

Coverage Industries

IndustryPercentage
Miscellaneous
1 company
50.0%
CONSUMER STAPLES DISTRIBUTION & RETAIL
1 company
50.0%

Joseph Thomas' Ratings History at Oppenheimer

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
City Therapeutics, Inc. stock logo
CTY
City Therapeutics
11/10/2026Initiated Coverage$18.67$46.00Outperform
Walmart Inc. stock logo
WMT
Walmart
2/20/2026Downgrade$124.87$131.00Hold